These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34503204)

  • 41. Identification of novel potential homologous repair deficiency-associated genes in pancreatic adenocarcinoma via WGCNA coexpression network analysis and machine learning.
    Liu C; Fang J; Kang W; Yang Y; Yu C; Chen H; Zhang Y; Ouyang H
    Cell Cycle; 2023 Nov; 22(21-22):2392-2408. PubMed ID: 38124367
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Profiles of genomic instability in high-grade serous ovarian cancer predict treatment outcome.
    Wang ZC; Birkbak NJ; Culhane AC; Drapkin R; Fatima A; Tian R; Schwede M; Alsop K; Daniels KE; Piao H; Liu J; Etemadmoghadam D; Miron A; Salvesen HB; Mitchell G; DeFazio A; Quackenbush J; Berkowitz RS; Iglehart JD; Bowtell DD; ; Matulonis UA
    Clin Cancer Res; 2012 Oct; 18(20):5806-15. PubMed ID: 22912389
    [TBL] [Abstract][Full Text] [Related]  

  • 43. How BRCA and homologous recombination deficiency change therapeutic strategies in ovarian cancer: a review of literature.
    Arcieri M; Tius V; Andreetta C; Restaino S; Biasioli A; Poletto E; Damante G; Ercoli A; Driul L; Fagotti A; Lorusso D; Scambia G; Vizzielli G
    Front Oncol; 2024; 14():1335196. PubMed ID: 38525421
    [TBL] [Abstract][Full Text] [Related]  

  • 44. T-Cell Receptor Gene Rearrangement Clonality, Flow Cytometry Status, and Associated Outcomes in Early-Stage Cutaneous T-Cell Lymphoma.
    Marks JA; Switchenko JM; Martini DJ; Tarabadkar ES; Khan MK; Lechowicz MJ; Allen PB
    JAMA Dermatol; 2021 Aug; 157(8):954-962. PubMed ID: 34190977
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Comprehensive Analysis of Prognostic Indicators in Serous Ovarian Cancer Based on Leukocyte Migration and Immune Microenvironment.
    Pan J; Chen X; Yang L; Song Y; Liu J; Li L; Lin Y; Tang L; Qiu S; Xu Q
    Front Biosci (Landmark Ed); 2023 Jun; 28(6):130. PubMed ID: 37395023
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of biomarkers complementary to homologous recombination deficiency for improving the clinical outcome of ovarian serous cystadenocarcinoma.
    Shi Z; Zhao Q; Lv B; Qu X; Han X; Wang H; Qiu J; Hua K
    Clin Transl Med; 2021 May; 11(5):e399. PubMed ID: 34047476
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Establish of an Initial Platinum-Resistance Predictor in High-Grade Serous Ovarian Cancer Patients Regardless of Homologous Recombination Deficiency Status.
    Li Y; Nie Y; Guo H; Guo H; Ha C; Li Y
    Front Oncol; 2022; 12():847085. PubMed ID: 35372049
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of homologous recombination deficiency testing in ovarian cancer and its clinical implications: do we need it?
    Ngoi NYL; Tan DSP
    ESMO Open; 2021 Jun; 6(3):100144. PubMed ID: 34015643
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Signatures associated with homologous recombination deficiency and immune regulation to improve clinical outcomes in patients with lung adenocarcinoma.
    Shang X; Qi K; Liu X; Liu Q; Zhang X; Wang D; Huang W
    Front Oncol; 2022; 12():854999. PubMed ID: 36249053
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Homologous repair deficiency-associated genes in invasive breast cancer revealed by WGCNA co-expression network analysis and genetic perturbation similarity analysis.
    Chen H; Liu Y; Yin Z; Chen H; Wang Y; Qian Y
    Cell Cycle; 2023 May; 22(9):1077-1100. PubMed ID: 36757135
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incorporating RNA-based Risk Scores for Genomic Instability to Predict Breast Cancer Recurrence and Immunogenicity in a Diverse Population.
    Hamilton AM; Van Alsten SC; Gao X; Nsonwu-Farley J; Calhoun BC; Love MI; Troester MA; Hoadley KA
    Cancer Res Commun; 2023 Jan; 3(1):12-20. PubMed ID: 36968228
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A transcriptional signature detects homologous recombination deficiency in pancreatic cancer at the individual level.
    Zhuang S; Chen T; Li Y; Wang Y; Ai L; Geng Y; Zou M; Liu K; Xu H; Wang L; Zhao Z; Chang Z; Gu Y
    Mol Ther Nucleic Acids; 2021 Dec; 26():1014-1026. PubMed ID: 34786207
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Homologous recombination deficiency serves as a prognostic biomarker in clear cell renal cell carcinoma.
    He L; Gao F; Zhu J; Xu Q; Yu Q; Yang M; Huang Y
    Exp Ther Med; 2023 Sep; 26(3):429. PubMed ID: 37602311
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical significance of T cell clonality and expression levels of immune-related genes in endometrial cancer.
    Ikeda Y; Kiyotani K; Yew PY; Sato S; Imai Y; Yamaguchi R; Miyano S; Fujiwara K; Hasegawa K; Nakamura Y
    Oncol Rep; 2017 May; 37(5):2603-2610. PubMed ID: 28358435
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular analysis of endometrial serous carcinoma reveals distinct clinicopathologic and genomic subgroups.
    Lin DI; Fine A; Danziger NA; Huang RSP; Mata DA; Decker B; Killian JK; Ramkissoon SH; Lechpammer M; Janovitz T; Ross JS; Sokol ES; Elvin JA
    Gynecol Oncol; 2022 Mar; 164(3):558-565. PubMed ID: 34998597
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genomic Instability Promotes the Progression of Clear Cell Renal Cell Carcinoma Through Influencing the Immune Microenvironment.
    Wei X; Wang Y; Ji C; Luan J; Yao L; Zhang X; Wang S; Yao B; Qin C; Song N
    Front Genet; 2021; 12():706661. PubMed ID: 34712264
    [No Abstract]   [Full Text] [Related]  

  • 57. Pan-Cancer Analysis of Copy-Number Features Identifies Recurrent Signatures and a Homologous Recombination Deficiency Biomarker to Predict Poly (ADP-Ribose) Polymerase Inhibitor Response.
    Moore JA; Chen KT; Madison R; Newberg JY; Fleischmann Z; Wang S; Sharaf R; Murugesan K; Fendler BJ; Hughes J; Schrock AB; Hegde PS; Oxnard GR; Fabrizio D; Frampton GM; Antonarakis ES; Sokol ES; Jin DX
    JCO Precis Oncol; 2023 Sep; 7():e2300093. PubMed ID: 37769224
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients.
    Truxova I; Kasikova L; Hensler M; Skapa P; Laco J; Pecen L; Belicova L; Praznovec I; Halaska MJ; Brtnicky T; Salkova E; Rob L; Kodet R; Goc J; Sautes-Fridman C; Fridman WH; Ryska A; Galluzzi L; Spisek R; Fucikova J
    J Immunother Cancer; 2018 Dec; 6(1):139. PubMed ID: 30526667
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer.
    Laumont CM; Wouters MCA; Smazynski J; Gierc NS; Chavez EA; Chong LC; Thornton S; Milne K; Webb JR; Steidl C; Nelson BH
    Clin Cancer Res; 2021 Jul; 27(14):4089-4100. PubMed ID: 33963000
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting DNA repair: the genome as a potential biomarker.
    Nesic K; Wakefield M; Kondrashova O; Scott CL; McNeish IA
    J Pathol; 2018 Apr; 244(5):586-597. PubMed ID: 29282716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.